Cargando…

SUN-593 Variants in Known Monogenic Causal Genes of Hypertriglyceridemia Are Not Major Contributors for Hypertriglyceridemia in Lipodystrophy Due to a LMNA Mutation

Background: Lipodystrophy is a heterogeneous disorder of adiposity, and one common lipid manifestation is hypertriglyceridemia (HTG). The LMNA gene, which encodes for nuclear envelope proteins, is a known causal gene for heritable lipodystrophy. At present, underlying mechanisms for each clinical ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ueda, Masako, McIntyre, Adam D, Remaley, Alan T, Hegele, Robert A, Rader, Daniel J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Adipose Tissue, Appetite, and Obesity
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207791/ http://dx.doi.org/10.1210/jendso/bvaa046.103

Ejemplares similares

Novel Heterozygous LMNA Variants Causing Familial Partial Lipodystrophy, Dunnigan Variety
por: Wadhwa, Akhilesh, et al.
Publicado: (2021)

FRI055 LYNC-LD: Prospective Multicenter Natural History Study Of Lipodystrophy Syndromes To Determine Prevalence, Incidence And Predictors Of Diabetes And Severe Hypertriglyceridemia, And Their Complications
por: Foss de Freitas, Maria Cristina, et al.
Publicado: (2023)

Impact of Morbid Obesity on Patients With Hypertriglyceridemia Induced Acute Pancreatitis
por: Pudasaini, Garima, et al.
Publicado: (2021)

SUN-600 Presence of LMNA p.R582H Pathogenic Variant in Homozygous State Demonstrates Gene Dosage Effect on the Severity of Fat Loss in Lipodystrophy
por: Soyaltin, Utku Erdem, et al.
Publicado: (2020)

RF24 | PSUN126 A Very-Low Calorie Diet Can Reduce Insulin Resistance and Cause Remission of Diabetes Mellitus and Hypertriglyceridemia in a Patient With Familial Partial Lipodystrophy Type 2
por: De Freitas, Maria Foss, et al.
Publicado: (2022)

SUN-607 Iron Parameters in Patients with Partial Lipodystrophy and Impact of Metreleptin Therapy
por: Boutros, Sabine, et al.
Publicado: (2020)

MON-593 Single-Dose Effects of Anti-Obesity Drugs on Human Basal Metabolic Rate
por: Israni, Nikita Sanjay, et al.
Publicado: (2020)

SAT-593 Sex-Specific Modifications in MicroRNAs Contained in Exosomes of Astrocytes in Response to Palmitic Acid
por: Chowen, Julie Ann, et al.
Publicado: (2020)

Untangling the Heterogeneity of Acquired Generalized Lipodystrophy
por: Cavdar, Umit, et al.
Publicado: (2021)

SUN-610 Acquired Generalized Lipodystrophy: A Rare Side Effect of PD1-Inhibitor Therapy
por: Shah, Amy, et al.
Publicado: (2020)

SAT674 Lipodystrophy: A Hidden Culprit In Uncontrolled Diabetes
por: Sayed, Farah El, et al.
Publicado: (2023)

Leptin Decreases Energy Expenditure but Increases Thyroid Hormone in Patients With Lipodystrophy
por: Quaye, Emmanuel, et al.
Publicado: (2021)

FRI054 Partial Lipodystrophy As A Manifestation Of Autoimmune Polyglandular Syndrome 1
por: Agarwal, Shubham, et al.
Publicado: (2023)

Metabolic Improvements After Gastric Sleeve Surgery in a Patient With Familial Partial Lipodystrophy
por: Niaz, Azra, et al.
Publicado: (2021)

FRI056 Effect Of 48 Hour Of Metreleptin In Humans With Lipodystrophy During Controlled Feeding
por: Bukhari, Khulood M, et al.
Publicado: (2023)

SAT676 Severe Recurrent Pancreatitis In A Familial Partial Lipodystrophy Patient On Metreleptin
por: Sargin, Pinar, et al.
Publicado: (2023)

MON-100 Unique miRNA Signature in HIV Lipodystrophy with Reduced Adipose Dicer Expression
por: Srinivasa, Suman, et al.
Publicado: (2019)

OR33-07 ARNT2: A Potential Novel Candidate Gene for Monogenic Obesity in Humans
por: Thaker, Vidhu V, et al.
Publicado: (2020)

RF12 | PSUN80 A Novel DXA Algorithm to Aid in the Diagnosis of Familial Partial Lipodystrophy
por: Harris, Charles, et al.
Publicado: (2022)

Abnormal Non Esterified Fatty Acid Suppression After a Mixed Meal Test in Patients With Partial Lipodystrophy
por: de Freitas, Maria Cristina Foss, et al.
Publicado: (2021)

OR07-01 Aberrant Expression Of Agouti Signaling Protein (ASIP) As A Cause of Monogenic Severe Childhood Obesity
por: Landgraf, Kathrin, et al.
Publicado: (2023)

MON-101 The LD Lync Study: Natural History Study of Lipodystrophy Syndromes: Early Lessons from the Pilot Data
por: Jalal Eldin, Abdelwahab, et al.
Publicado: (2019)

OR33-02 The Treatment of Partial Lipodystrophy in the Setting of Neutralizing Antibody Against Metreleptin with Leptin Receptor Agonist REGN4461
por: Akinci, Baris, et al.
Publicado: (2020)

Inhibition of Angiopoietin-Like 3 (ANGPTL3) Reduces Adipose Tissue Insulin Resistance in Patients With Familial Partial Lipodystrophy
por: de Freitas, Maria Cristina Foss, et al.
Publicado: (2021)

FRI057 Drug Concentrations And Dosing Considerations For Mibavademab, A Novel Leptin Receptor Agonist, In Individuals With Generalized Lipodystrophy
por: Mendell, Jeanne, et al.
Publicado: (2023)

FRI059 Long-term Follow-up On Partial Lipodystrophy Treated With Leptin Receptor Agonist Mibavademab(REGN4461)
por: Foss de Freitas, Maria Cristina, et al.
Publicado: (2023)

FRI058 Treatment With Mibavademab, A Novel Leptin Receptor Agonist, Is Associated With Improvement In Metabolic Parameters In Individuals With Generalized Lipodystrophy
por: Olenchock, Ben, et al.
Publicado: (2023)

PSUN81 A novel case of congenital generalized lipodystrophy (CGL) with no genetic abnormalites in the AGPAT2, BSCL2, CAV1, and CAVIN1 genes.
por: Mericq, Veronica, et al.
Publicado: (2022)

FRI018 A Novel Truncating Variant Of EBF2 Disrupts Human Adipocyte Differentiation In Lipodystrophy Syndromes: An Example Of A Discovery From A Clinical Translational Pipeline
por: Foss de Freitas, Maria Cristina, et al.
Publicado: (2023)

FRI076 Colchicine Treatment Effects On The Gut Microbiome In Adults With Metabolic Syndrome, Insulin Resistance, And High C-reactive Protein (CRP): A Secondary Analysis Of A Randomized, Placebo-controlled Clinical Trial
por: Kisimba, Celine M, et al.
Publicado: (2023)

SUN-584 Micrornas in Brown and White Adipocytes
por: Dimitri, Federica, et al.
Publicado: (2020)

SUN-110 The Role Of RasD2 In Metabolism And Obesity
por: Fong, Vincent, et al.
Publicado: (2019)

SUN-LB020 The Role of Estradiol and Diet on the Gut Microbiome
por: Thumuluri, Deepthi, et al.
Publicado: (2019)

SUN-109 PTEN Regulates Differentiation and Proliferation of Aging Preadipocytes
por: Kirstein, Anna, et al.
Publicado: (2019)

SUN-594 Pubertal Timing and Hormonal Correlates in Male Obesity
por: De Schepper, Jean, et al.
Publicado: (2020)

SUN-586 CXCR2 Repression by Glucocorticoids in Adipose Tissue
por: Amatya, Shripa, et al.
Publicado: (2020)

SUN-LB017 Cellular and Synaptic Reorganization after Exercise Training
por: Williams, Kevin
Publicado: (2019)

SUN-598 Phenotypic Study of Meso-Somatous (Roch-Leri) Lipomatosis
por: Lemaitre, Madleen, et al.
Publicado: (2020)

SUN-606 Identification of NASH Using Data from NHANES III
por: Friedman, Theodore C, et al.
Publicado: (2020)

SUN-590 27-Hydroxycholesterol Triggers the Whitening of Brown Adipose Tissue
por: Asghari, Arvand, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_us31tkfs5dh6nihne62tj93stv